Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014, Article ID 310750, 4 pages
http://dx.doi.org/10.1155/2014/310750
Case Report

Recurrent and Progressive Abdominal Pain and Enteritis in a Japanese Patient with Paroxysmal Nocturnal Hemoglobinuria

1Department of Internal Medicine, Minoh City Hospital, 7-1 Kayano 5-chome, Minoh City, Osaka 562-0014, Japan
2Department of Hematology and Chemotherapy, Osaka Medical Center for Cancer and Cardiovascular Diseases, 8-13F, 1-3-2 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan

Received 14 May 2013; Accepted 24 June 2013; Published 27 January 2014

Academic Editors: E. Arellano-Rodrigo, K. Konstantopoulos, and F. Kutlar

Copyright © 2014 Akihisa Hino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. C. Weitz, “Thrombosis in patients with paroxysmal nocturnal hemoglobinuria,” Seminars in Thrombosis and Hemostasis, vol. 37, no. 3, pp. 315–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Hillmen, S. M. Lewis, M. Bessler, L. Luzzatto, and J. V. Dacie, “Natural history of paroxysmal nocturnal hemoglobinuria,” New England Journal of Medicine, vol. 333, no. 19, pp. 1253–1258, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Socié, J.-Y. Mary, A. De Gramont et al., “Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors,” The Lancet, vol. 348, no. 9027, pp. 573–577, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. K. McKeage, “Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria,” Drugs, vol. 71, no. 17, pp. 2327–2345, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Hillmen, P. Muus, U. Dührsen et al., “Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria,” Blood, vol. 110, no. 12, pp. 4123–4128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-I. Nishimura, Y. Kanakura, R. E. Ware et al., “Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan,” Medicine, vol. 83, no. 3, pp. 193–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Cella, K. Webster, and J. Beaumont, The FACIT-Fatigue Scale: Description, Reliability and Validity, Center on Outcomes, Research and Education, Evanston, Ill, USA, 2003.
  8. J. Torres, B. De Vroey, M.-P. Noël, B. Notteghem, and J.-F. Colombel, “Recurrent small bowel ischemia in a patient with paroxysmal nocturnal hemoglobinuria,” Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 7, pp. 410–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Meyers, I. Weitz, T. Lamy et al., “Disease-related symptoms reported across a broad population of patients with paroxysmal nocturnal hemoglobinuria,” Blood (ASH Annual Meeting Abstracts), vol. 110, no. 11, p. 3683, 2007. View at Google Scholar
  10. P. Muus, J. Szer, H. Schrezenmeier et al., “Evaluation of paroxysmal nocturnal hemoglobinuria disease burden: the patient's perspective. A report from the International PNH Registry,” Blood, vol. 116, no. 21, abstract 1525, 2010. View at Google Scholar
  11. J. Lee, J. Jun Ho, Y. Sung Soo et al., “High prevalence and mortality associated with thromboembolism in Asian patients with paroxysmal nocturnal hemoglobinuria (PNH),” Haematologica, vol. 95, no. 205, abstract 0505, supplement 2, pp. 205–206, 2010. View at Google Scholar
  12. M. T. Gladwin, J. H. Crawford, and R. P. Patel, “The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation,” Free Radical Biology and Medicine, vol. 36, no. 6, pp. 707–717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, “The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease,” Journal of the American Medical Association, vol. 293, no. 13, pp. 1653–1662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Schäfer, F. Wiesmann, S. Neubauer, M. Eigenthaler, J. Bauersachs, and K. M. Channon, “Rapid regulation of platelet activation in vivo by nitric oxide,” Circulation, vol. 109, no. 15, pp. 1819–1822, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. I. Ataga, “Hypercoagulability and thrombotic complications in hemolytic anemias,” Haematologica, vol. 94, no. 11, pp. 1481–1484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. I. C. Weitz, P. Razavi, L. Rochanda et al., “Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation,” Thrombosis Research, vol. 130, no. 2, pp. 361–368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Helley, R. P. de Latour, R. Porcher et al., “Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab,” Haematologica, vol. 95, no. 4, pp. 574–581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. J. Borowitz, F. E. Craig, J. A. DiGiuseppe et al., “Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry,” Cytometry B, vol. 78, no. 4, pp. 211–230, 2010. View at Publisher · View at Google Scholar · View at Scopus